Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Oslo Antioxidant Study

This study has been completed.
Sponsor:
Collaborator:
Ullevaal University Hospital
Information provided by:
University of Oslo
ClinicalTrials.gov Identifier:
NCT00520819
First received: August 24, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted